Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse

被引:0
|
作者
Bremner, JD [1 ]
Southwick, SM [1 ]
Darnell, A [1 ]
Charney, DS [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT
来源
AMERICAN JOURNAL OF PSYCHIATRY | 1996年 / 153卷 / 03期
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The purpose of this study was to measure the longitudinal course of specific symptoms of posttraumatic stress disorder (PTSD) and related symptoms of alcohol and substance abuse and the effects of alcohol and substances on the symptoms of PTSD. Method: A structured interview for the assessment of PTSD and alcohol and substance abuse, as well as other factors such as life stressors and treatment, was administered to 61 Vietnam combat veterans with PTSD. Results: Onset of symptoms typically occurred at the time of exposure to combat trauma in Vietnam and increased rapidly during the first few years after the war. Symptoms plateaued within a few years after the tear, following which the disorder became chronic and unremitting. Hyperarousal symptoms such as feeling on guard and feeling easily startled developed first, followed by avoidant symptoms and finally by symptoms from the intrusive cluster. The onset of alcohol and substance abuse typically was associated with the onset of symptoms of PTSD, and the increase in use paralleled the increase of symptoms. Patients reported a tendency for alcohol, marijuana, heroin, and benzodiazepines to make PTSD symptoms better, while cocaine made symptoms in the hyperarousal category worse. There was no relationship between treatment interventions and the natural course of PTSD. Conclusions: These findings suggest that symptoms of PTSD begin soon after exposure to trauma, that hyperarousal symptoms are the first symptoms to occur, that the natural course of alcohol and substance abuse parallels that of PTSD, and that specific substances have specific effects on PTSD symptoms.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 50 条
  • [1] The consistency of combat exposure reporting and course of PTSD in Vietnam war veterans
    Koenen, K. C.
    Stellman, S. D.
    Dohrenwend, B. P.
    Sommer, J. F., Jr.
    Stellman, J. M.
    JOURNAL OF TRAUMATIC STRESS, 2007, 20 (01) : 3 - 13
  • [2] HIDDEN PTSD IN SUBSTANCE-ABUSE INPATIENTS AMONG VIETNAM VETERANS
    HYER, L
    LEACH, P
    BOUDEWYNS, PA
    DAVIS, H
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1991, 8 (04) : 213 - 219
  • [3] A PTSD TREATMENT PROGRAM FOR COMBAT (VIETNAM) VETERANS IN PRISON
    SIGAFOOS, CE
    INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY, 1994, 38 (02) : 117 - 130
  • [4] CONVERGENT VALIDITY OF MEASURES OF PTSD IN VIETNAM COMBAT VETERANS
    MCFALL, ME
    SMITH, DE
    ROSZELL, DK
    TARVER, DJ
    MALAS, KL
    AMERICAN JOURNAL OF PSYCHIATRY, 1990, 147 (05): : 645 - 648
  • [5] SUICIDE AND GUILT AS MANIFESTATIONS OF PTSD IN VIETNAM COMBAT VETERANS
    HENDIN, H
    HAAS, AP
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (05): : 586 - 591
  • [6] Neuropsychological assessment of Vietnam combat veterans with and without PTSD
    Gilbertson, MW
    Gurvits, TV
    Lasko, NB
    Pitman, RK
    PSYCHOBIOLOGY OF POSTTRAUMATIC STRESS DISORDER, 1997, 821 : 476 - 479
  • [7] The Course and Correlates of Combat-Related PTSD in Australian Vietnam Veterans in the Three Decades After the War
    O'Toole, Brian I.
    Catts, Stanley V.
    JOURNAL OF TRAUMATIC STRESS, 2017, 30 (01) : 27 - 35
  • [8] RATE OF COMBAT RELATED STRESS (PTSD) IN VETERANS SEEKING SUBSTANCE-ABUSE TREATMENT SERVICES AT A VETERANS-ADMINISTRATION HOSPITAL
    PASHKO, S
    DRULEY, KA
    ALVAREZ, N
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1986, 10 (01) : 99 - 99
  • [9] COMBAT-RELATED POSTTRAUMATIC-STRESS-DISORDER AND SEVERITY OF SUBSTANCE-ABUSE IN VIETNAM VETERANS
    MCFALL, ME
    MACKAY, PW
    DONOVAN, DM
    JOURNAL OF STUDIES ON ALCOHOL, 1992, 53 (04): : 357 - 363
  • [10] Adjunctive risperidone treatment in combat veterans with chronic PTSD
    David, D
    De Faria, L
    Lapeyra, O
    Mellman, TA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (05) : 556 - 559